Prokidney Corp. (PROK)
NASDAQ:PROK
Want to see PROK full AI Analyst Report?
Total Valuation
ProKidney has a market cap or net worth of $510.31M. The enterprise value is $446.46M.
Market Cap$510.31M
Enterprise Value$446.46M
Share Statistics
ProKidney has 141,987,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding141,987,950
Owned by Insiders70.93%
Owned by Institutions12.58%
Financial Efficiency
ProKidney’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is -54.13%.
Return on Equity (ROE)0.07
Return on Assets (ROA)-0.21
Return on Invested Capital (ROIC)-54.13%
Return on Capital Employed (ROCE)-0.54
Revenue Per Employee4.38K
Profits Per Employee-743.20K
Employee Count204
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of ProKidney is ―. ProKidney’s PEG ratio is 0.27.
PE Ratio―
PS Ratio335.98
PB Ratio-0.30
Price to Fair Value-0.30
Price to FCF-2.22
Price to Operating Cash Flow-1.81
PEG Ratio0.27
Income Statement
In the last 12 months, ProKidney had revenue of 893.00K and earned -68.99M in profits. Earnings per share was -0.52.
Revenue893.00K
Gross Profit893.00K
Operating Income-165.01M
Pretax Income-151.20M
Net Income-68.99M
EBITDA-144.62M
Earnings Per Share (EPS)-0.52
Cash Flow
In the last 12 months, operating cash flow was -132.21M and capital expenditures -17.85M, giving a free cash flow of -150.06M billion.
Operating Cash Flow-132.21M
Free Cash Flow-150.06M
Free Cash Flow per Share-1.06
Dividends & Yields
ProKidney pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.16
52-Week Price Change119.48%
50-Day Moving Average1.90
200-Day Moving Average2.31
Relative Strength Index (RSI)41.46
Average Volume (3m)930.88K
Important Dates
ProKidney upcoming earnings date is Aug 6, 2026, After Close (Confirmed).
Last Earnings DateMay 15, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
ProKidney as a current ratio of 9.13, with Debt / Equity ratio of -0.37%
Current Ratio9.13
Quick Ratio9.13
Debt to Market Cap0.00
Net Debt to EBITDA0.73
Interest Coverage Ratio-41.25K
Taxes
In the past 12 months, ProKidney has paid 414.00K in taxes.
Income Tax414.00K
Effective Tax Rate>-0.01
Enterprise Valuation
ProKidney EV to EBITDA ratio is -3.98, with an EV/FCF ratio of -4.25.
EV to Sales644.27
EV to EBITDA-3.98
EV to Free Cash Flow-4.25
EV to Operating Cash Flow-4.79
Balance Sheet
ProKidney has $224.94M in cash and marketable securities with $3.78M in debt, giving a net cash position of $221.16M billion.
Cash & Marketable Securities$224.94M
Total Debt$3.78M
Net Cash$221.16M
Net Cash Per Share$1.56
Tangible Book Value Per Share$2.25
Margins
Gross margin is -224.41%, with operating margin of -18477.83%, and net profit margin of -7725.20%.
Gross Margin-224.41%
Operating Margin-18477.83%
Pretax Margin-16931.47%
Net Profit Margin-7725.20%
EBITDA Margin-16194.74%
EBIT Margin-16931.02%
Analyst Forecast
The average price target for ProKidney is $5.42, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$5.42
Price Target Upside226.20% Upside
Analyst ConsensusHold
Analyst Count5
Revenue Growth Forecast190.52%
EPS Growth Forecast12.60%